ArticlePDF Available

Metallic stent insertion to relieve malignant bowel obstruction in a child: a case report

Authors:

Abstract

Self-expandable metallic stents (SEMS) have been widely used in adults to relieve obstruction secondary to colorectal tumours. However, there is a paucity of literature about their use in children, with only a few case reports describing stent insertion in children with benign colonic conditions. There is one case report on a malignant colonic condition in a child by Hussain et al. in the literature. However, due to the rarity of the condition, there are currently no guidelines from learned societies on colorectal SEMS placement in paediatric patients. We share our experience of using a fully covered SEMS to relieve malignant colonic obstruction in a 6 year-old-child, who was on treatment for T cell lymphoma. This was done as a bridge to surgery, thereby allowing planned surgery, and avoiding colostomy in this child, who went on to have colonic resection with primary anastomosis.
journals.sagepub.com/home/cmg 1
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License
(https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission
provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
https://doi.org/10.1177/26317745221111942
https://doi.org/10.1177/26317745221111942
Ther Adv Gastrointest
Endosc
2022, Vol. 15: 1–4
DOI: 10.1177/
26317745221111942
© The Author(s), 2022.
Article reuse guidelines:
sagepub.com/journals-
permissions
THERAPEUTIC ADVANCES in
Gastrointestinal Endoscopy
Case report
We report a case of a 6-year-old boy, who was on
maintenance chemotherapy for an underlying
diagnosis of stage IV T cell lymphoma with loss of
MLH1 and PMS2 expression on lymph node
biopsy (high probability of lynch syndrome). He
presented with a 1 day history of persistent
vomiting, abdominal distention and diarrhoea.
Investigations showed a haemoglobin of 11.2 g/dl.
Renal function, serum electrolytes and liver func-
tion tests were normal. An erect abdominal X-ray
showed dilated large and small bowel, with air-
fluid levels. A contrast-enhanced computed
tomography scan of the abdomen and pelvis con-
firmed proximal descending colon obstruction sec-
ondary to an annular stenosing mass. The child
was kept nil by mouth, intravenous fluids and anal-
gesia were started and a nasogastric tube was
inserted to decompress the bowel. An urgent pae-
diatric surgical opinion was sought. A diagnosis of
possible malignant large bowel obstruction was
made and gastroenterology review was advised. The
gastroenterologist advised unprepared sigmoidos-
copy, with biopsy and possible stent insertion. The
rationale for this was that this would relieve bowel
obstruction, allow time for a definitive histologic
diagnosis of the cause of bowel obstruction to be
made and potentially allow resection of the
obstructed segment of the bowel with primary
anastomosis, thus avoiding a colostomy in this very
young child. It was decided that, since specific pae-
diatric stents were not available and adult-sized
colonic stents would be inappropriate for a child, a
fully covered biliary self-expandable metallic stent
(SEMS), which has a smaller diameter and length
of 10 mm and 6 cm, respectively, as opposed to
20 mm and 13 cm for adult colonic stents, would
be used. After informed written consent was taken
from the patient’s parents, sigmoidoscopy was per-
formed under general anaesthesia the same day and
showed a polypoid stenosing tumour at 20 cm from
the anal verge, which was biopsied (Figure 1). A
6 cm × 10 mm fully covered (adult) self-expanding
biliary metallic stent was inserted under fluoro-
scopic assistance , as showed in Figures 2–4. This
allowed virtually immediate relief of obstruction,
with drainage of close to 1500 ml of liquid stool.
No immediate complications were observed. The
patient made a good recovery and was allowed
home 3 days later. The histology subsequently
revealed the tumour to be a poorly differentiated
carcinoma with neuroendocrine differentiation.
Metallic stent insertion to relieve malignant
bowel obstruction in a child: a case report
Sundus Bilal , Saad M. Saeed , Muhammad Z. Sidique
and Muhammed A. Yusuf
Abstract: Self-expandable metallic stents (SEMS) have been widely used in adults to relieve
obstruction secondary to colorectal tumours. However, there is a paucity of literature about
their use in children, with only a few case reports describing stent insertion in children with
benign colonic conditions. There is one case report on a malignant colonic condition in a
child by Hussain et al. in the literature. However, due to the rarity of the condition, there are
currently no guidelines from learned societies on colorectal SEMS placement in paediatric
patients. We share our experience of using a fully covered SEMS to relieve malignant colonic
obstruction in a 6 year-old-child, who was on treatment for T cell lymphoma. This was done
as a bridge to surgery, thereby allowing planned surgery, and avoiding colostomy in this child,
who went on to have colonic resection with primary anastomosis.
Keywords: bowel obstruction, case report, child, colorectal cancer, stents
Received: 2 December 2021; revised manuscript accepted: 20 June 2022.
Correspondence to:
Sundus Bilal
Shaukat Khanum
Memorial Cancer Hospital
and Research Centre, 7A,
Block R-3, Johar Town,
Lahore, Punjab 54000,
Pakistan
sundus.bilal@hotmail.com
Saad M. Saeed
Muhammad Z. Sidique
Muhammed A. Yusuf
Shaukat Khanum
Memorial Cancer Hospital
and Research Centre,
Lahore, Punjab, Pakistan
11119 42CMG0010.1177/26317745221111942Therapeutic Advances in Gastrointestinal EndoscopyS Bilal, SM Saeed
research-article20222022
Case Report
Volume 15
2 journals.sagepub.com/home/cmg
THERAPEUTIC ADVANCES in
Gastrointestinal Endoscopy
The patient then returned to the hospital 3 weeks
later, for an elective left hemicolectomy. The surgi-
cal specimen showed a poorly differentiated ade-
nocarcinoma with neuroendocrine and signet ring
cell differentiation, pT4 pN3 disease, with the
abdominal wall and left peritoneal wall deposits,
positive for metastatic disease. The patient was
restarted on chemotherapy for his underlying lym-
phoma, with a plan for possible further treatment
for his metastatic colorectal cancer (CRC).
Discussion
CRC is the third most common cancer in adults,
worldwide.1 However, it is rare in children, with
an incidence of one per million.2–4 Similarly, in
the adult population 8–13% of the patients pre-
sent with large bowel obstruction,5 although
malignant strictures are exceedingly rare in paedi-
atric patients.4,6,7 There is, therefore, a scarcity of
literature on the management of malignant bowel
obstruction in children, with no definite manage-
ment guidelines available, to date.2,3,6 A case
report exists of an infant in whom a removable
silicone stent was successfully placed for a benign
anastomotic stricture following surgery for
Hirschsprung’s disease.8 In a case series of five
patients, Lange etal.9 describe the use of metallic
stents for benign colorectal strictures with
Figure 2. After colonic stent insertion
Figure 1. Endoscopic view of the tumour. Figure 3. Guidewire passed through tumour.
Figure 4. After colonic stent placement.
S Bilal, SM Saeed et al.
journals.sagepub.com/home/cmg 3
variable results. There is just a single case report
published in 2004 by Hussain et al.10 who used
SEMS for relieving complete large bowel malig-
nant obstruction in a child. Similarly, due to its
rarity, no definitive treatment has been proposed
for children with malignant colorectal tumours
and the few case reports which do exist suggest
using adult chemotherapy protocols in children
presenting with CRC.11 Hence, one might infer
that similar management may be applied to
address malignant strictures in paediatric patients.
Historically, emergency surgery was considered
to be the treatment of choice in adults present-
ing with malignant bowel obstruction.3,4,12
However, this is associated with high morbidity
and mortality due to the hazards of operating
on patients with an unprepared bowel which
usually results in stoma formation.7,12 Metallic
stents, which have traditionally been used for
palliation, now are recommended as a bridge to
surgery for resectable obstructing colorectal
tumours.4,13 A meta-analysis by Allievi et al.7
compared the use of stents with emergency sur-
gery and found that use of the former was asso-
ciated with a shorter hospital stay, helped to
convert emergency to elective surgery, increased
the likelihood of primary anastomosis, avoided
surgery prior to diagnosis or staging, and was
associated with better quality of life.
Our institution is the largest tertiary care cancer
centre in the country and we have extensive expe-
rience in using metallic stents in adults, including
as a bridge to surgery for obstructing colorectal
tumours. Extrapolating the evidence from the lit-
erature and based upon our experience of using
stents in adults, we decided to treat malignant
bowel obstruction in this paediatric patient with
SEMS, with good effect. It is important to note
here that there are no commercially available
colonic stents for this age group6 and our adult-
sized colorectal stents appeared to be inappropri-
ate for a 6-year-old child, weighing only 15 kg.
We solved this issue using a fully covered self-
expandable biliary metallic stent, which had a
smaller diameter and length.
In conclusion, stents can be used to relieve malig-
nant bowel obstruction even in children, thereby
saving them from risks of emergency surgery, as
well as from stoma formation. Although this is a
rare condition, we feel that the use of stents is
likely to be of benefit in specialised centres such
as ours, and that this represents a useful addition
to the currently available forms of treatment for
such conditions.
This case has been reported according to case
report (CARE) guidelines 2013.14
Declarations
Ethics approval and consent to participate
Case report has been approved by the Institutional
Review Board of Shaukat Khanum Memorial
Cancer Hospital and Research Centre, Lahore.
IRB no. EX-21-10-21-01.
Consent for publication
Informed consent has been taken from the par-
ents of the patient for publication of case report
and has been documented in patient’s record,
hospital information system (HIS).
Author contribution(s)
Sundus Bilal: Writing – original draft.
Saad M. Saeed: Investigation; Methodology.
Muhammad Z. Sidique: Conceptualisation;
Writing – review & editing.
Muhammed A. Yusuf: Supervision; Writing –
review & editing.
ORCID iDs
Sundus Bilal https://orcid.org/0000-0003-
1739-5056
Saad M. Saeed https://orcid.org/0000-0002-
3112-5338
Funding
The authors received no financial support for the
research, authorship, and/or publication of this
article.
Conflict of interest statement
The authors declare that there is no conflict of
interest.
Availability of data and materials
Not applicable.
References
1. Sung H, Ferlay J, Siegel RL, etal. Global cancer
statistics 2020: GLOBOCAN estimates of
incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin 2021; 71: 209–249.
2. Ahmad HR, Faruk JA, Sholadoye TT, etal.
Carcinoma of the colon in a child. J Community
Support Oncol 2018; 16: E152–E155.
Volume 15
4 journals.sagepub.com/home/cmg
THERAPEUTIC ADVANCES in
Gastrointestinal Endoscopy
3. Goldberg J and Furman WL. Management of
colorectal carcinoma in children and young
adults. J Pediatr Hematol Oncol 2012; 34:
S76–S79.
4. Morino M, Arezzo A, Farnesi F, etal. Colonic
stenting in the emergency setting. Medicina 2021;
57: 328.
5. Van Hooft JE, Veld JV, Arnold D, etal. Self-
expandable metal stents for obstructing colonic
and extracolonic cancer: European Society of
Gastrointestinal Endoscopy (ESGE) guideline–
update 2020. Endoscopy 2020; 52: 389–407.
6. Venezia L, Michielan A, Condino G, etal.
Feasibility and safety of self-expandable metal
stent in nonmalignant disease of the lower
gastrointestinal tract. World J Gastrointest Endosc
2020; 12: 60.
7. Allievi N, Ceresoli M, Fugazzola P, etal.
Endoscopic stenting as bridge to surgery versus
emergency resection for left-sided malignant
colorectal obstruction: an updated meta-analysis.
Int J Surg Oncol 2017; 2017: 2863272.
8. Rullán R, Danielson P, Hirsh M, etal. Self-
expanding silicone stent for treatment of
postoperative colorectal stricture in an infant with
Hirschsprung’s disease: a case report. Journal of
Pediatr Surg 2006; 41: 1613–1615.
9. Lange B, Sold M, Kähler G, etal. Use of covered
self-expandable stents for benign colorectal
disorders in children. J Pediatr Surg 2017; 52:
184–187.
10. Hussain SZ, Bashir RM, Kerzner B, etal. CASE
REPORT: Application of a self-expandable
metal stent (SEMS) in a child with complete
malignant large bowel obstruction. Dig Dis Sci
2004; 49: 1145–1148.
11. Pratt CB, Rao BN, Merchant TE, etal.
Treatment of colorectal carcinoma in
adolescents and young adults with surgery,
5-fluorouracil/leucovorin/interferon-alpha 2a
and radiation therapy. Med Pediatr Oncol 1999;
32: 459–460.
12. Kim EJ and Kim YJ. Stents for colorectal
obstruction: past, present, and future. World J
Gastroenterol 2016; 22: 842.
13. Saeed KM, Zafar W, Masood MA, etal. Self-
expanding metallic stents (SEMS) in left-sided
colonic cancer: a cancer center experience. J
Gastrointest Cancer 2016; 47: 69–74.1
14. Munk N and Boulanger K. Adaptation of the
CARE guidelines for therapeutic massage and
bodywork publications: efforts to improve
the impact of case reports. Int J Ther Massage
Bodywork 2014; 7: 32–40.
Visit SAGE journals online
journals.sagepub.com/
home/cmg
SAGE journals
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Nowadays, colorectal cancer (CRC) is the third most frequent cancer, and about a third of patients with CRC presents themselves with symptoms of large bowel obstruction. Historically, surgical resection was the treatment of choice for colonic obstruction, but this kind of approach is burdened by a high risk of postoperative morbidity and mortality. In recent times, the use of a colonic stent has been proposed to overcome the obstruction and transform an emergency surgical case into an elective one to avoid emergency surgery complications. Endoscopic stenting is the first-line treatment option in the palliative management of colonic obstruction, and there is sufficient scientific evidence to support this approach. However, endoscopic stent used as a bridge to surgery is not yet widely adopted because the concern was raised about the long-term survival and cancer safety of this approach. The recent scientific evidence has shown that this approach improves the short-term outcomes, such as postoperative complications and the stoma rate, without differences in long-term outcomes compared to emergency surgery. Therefore, the European Society for Gastrointestinal Endoscopy in 2020 has reconsidered stenting as a bridge to surgery as a valid alternative to emergency surgery.
Article
Full-text available
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2‐fold to 3‐fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2‐fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
Article
Full-text available
In recent years, self-expandable metal stents (SEMSs) have been employed to treat benign gastrointestinal strictures secondary to several conditions: Acute diverticulitis, radiation colitis, inflammatory bowel disease (IBD), and postanastomotic leakages and stenosis. Other applications include endometriosis and fistulas of the lower gastrointestinal tract. Although it may be technically feasible to proceed to stenting in the aforementioned benign diseases of the lower gastrointestinal tract, the outcome has been reported to be poor. In fact, in some settings (such as complicated diverticulitis and postsurgical anastomotic strictures), stenting seems to have a limited evidence-based benefit as a bridge to surgery, while in other settings (such as endometriosis, IBD, radiation colitis, etc.), even society guidelines are not able to guide the endoscopist through decisional algorithms for SEMS placement. The aim of this narrative paper is to review the scientific evidence regarding the use of SEMSs in nonmalignant diseases of the lower gastrointestinal tract, both in adult and pediatric settings.
Article
Full-text available
Introduction Emergency resection represents the traditional treatment for left-sided malignant obstruction. However, the placement of self-expanding metallic stents and delayed surgery has been proposed as an alternative approach. The aim of the current meta-analysis was to review the available evidence, with particular interest for the short-term outcomes, including a recent multicentre RCT. Methods We considered randomized controlled trials comparing stenting as a bridge to surgery and emergency surgery for the management of left-sided malignant large bowel obstruction, performing a systematic review in MEDLINE, PubMed database, and the Cochrane libraries. Results We initially identified a total of 2543 studies. After the elimination of duplicates and the screening of titles and abstracts, seven studies, for a total of 448 patients, were considered. The current meta-analysis revealed no difference in the mortality rate between the stent group and the emergency surgery group; the postoperative complication rate (37.84% versus 54.87%, P = 0.02), the stoma rate (28.8% versus 46.02%, P < 0.0001), and the incidence of wound infection (8.11% versus 15.49%, P = 0.01) were reduced after stent as a bridge to surgery. Conclusion Colonic stenting as a bridge to surgery appears to be a safe approach to malignant large bowel obstruction. Possible advantages of this treatment can be identified in a reduced incidence of postoperative complications and a lower stoma rate. Further RCTs considering long-term outcomes and cost-effectiveness analysis are needed.
Article
Full-text available
Since the development of uncovered self-expanding metal stents (SEMS) in the 1990s, endoscopic stents have evolved dramatically. Application of new materials and new designs has expanded the indications for enteral SEMS. At present, enteral stents are considered the first-line modality for palliative care, and numerous types of enteral stents are under development for extended clinical usage, beyond a merely palliative purpose. Herein, we will discuss the current status and the future development of lower enteral stents.
Article
Full-text available
Background and study aims: Self-Expanding Metallic Stents (SEMS) are a surgery-sparing option for malignant colonic obstruction. They can be inserted as a "bridge to surgery" (BTS) for potentially curable disease, or as a palliative measure, thereby avoiding the higher morbidity and mortality associated with surgery. The objective of this study was to report our local experience of left-sided colonic stents. Methods: Data on 49 patients was collected retrospectively from Oct 2008 to Nov 2014 at our cancer centre. This included demographics, baseline clinical characteristics, indications for SEMS placement (bridge to surgery/palliative), technical and clinical success, complications, and the mean patency of duration. Survival in both groups was also plotted on a Kaplan-Meier chart. Results: A total of 49 patients with colorectal carcinoma (CRC) of the left side were enrolled. The mean age was 50 years (range 18-86). Ninety percent of patients had disease involving the rectum, sigmoid colon, or both. Forty-seven percent (n = 23) of patients had stent insertion as a BTS, whereas 53 % (n = 26) had the procedure with palliative intent. Technical and clinical success rates were 96 and 88 %, respectively. The clinical success rate of the palliative arm was lower than that of the BTS arm (p = 0.024). 87.5 % (n = 42) had no procedure-related complications. Technical failure, perforation, and stent migration/expulsion, were each observed in 4 % of cases. Mean stent patency duration was 83.9 days. Conclusion: SEMS insertion for left-sided malignant colonic obstruction is a safe and effective procedure when used either as a bridge to surgery or with palliative intent.
Article
Full-text available
Case reports provide the foundation of practice-based evidence for therapeutic massage and bodywork (TMB), as well as many other health-related fields. To improve the consistency of information contained in case reports, the CARE (CAse REport) Group developed and published a set of guidelines for the medical community to facilitate systematic data collection (http://www.care-statement.org/#). Because of the differences between the practice of medicine and TMB, modifying some sections of the CARE guidelines is necessary to make them compatible with TMB case reports. Accordingly, the objectives of this article are to present the CARE guidelines, apply each section of the guidelines to TMB practice and reporting with suggested adaptations, and highlight concerns, new ideas, and other resources for potential authors of TMB case reports. The primary sections of the CARE guidelines adapted for TMB case reports are diagnostic assessment, follow-up and outcomes, and therapeutic intervention. Specifically, because diagnosis falls outside of the scope of most TMB practitioners, suggestions are made as to how diagnoses made by other health care providers should be included in the context of a TMB case report. Additionally, two new aspects of the case presentation section are recommended: a) assessment measures, which outline and describe the outcome measures on which the case report will focus, and b) a description of the TMB provider (i.e., scope of practice, practice environment, experience level, training, credentialing, and/or expertise) as part of the intervention description. This article culminates with practical resources for TMB practitioners writing case reports, including a TMB Case Report Template—a single document that TMB practitioners can use to guide his or her process of writing a case report. Once the template is adopted by authors of TMB case reports, future efforts can explore the impact on the quality and quantity of case reports and how they impact TMB practice, research, education and, ultimately, the clients.
Article
Main Recommendations The following recommendations should only be applied after a thorough diagnostic evaluation including a contrast-enhanced computed tomography (CT) scan. 1 ESGE recommends colonic stenting to be reserved for patients with clinical symptoms and radiological signs of malignant large-bowel obstruction, without signs of perforation. ESGE does not recommend prophylactic stent placement. Strong recommendation, low quality evidence. 2 ESGE recommends stenting as a bridge to surgery to be discussed, within a shared decision-making process, as a treatment option in patients with potentially curable left-sided obstructing colon cancer as an alternative to emergency resection. Strong recommendation, high quality evidence. 3 ESGE recommends colonic stenting as the preferred treatment for palliation of malignant colonic obstruction. Strong recommendation, high quality evidence. 4 ESGE suggests consideration of colonic stenting for malignant obstruction of the proximal colon either as a bridge to surgery or in a palliative setting. Weak recommendation, low quality evidence. 5 ESGE suggests a time interval of approximately 2 weeks until resection when colonic stenting is performed as a bridge to elective surgery in patients with curable left-sided colon cancer. Weak recommendation, low quality evidence. 6 ESGE recommends that colonic stenting should be performed or directly supervised by an operator who can demonstrate competence in both colonoscopy and fluoroscopic techniques and who performs colonic stenting on a regular basis. Strong recommendation, low quality evidence. 7 ESGE suggests that a decompressing stoma as a bridge to elective surgery is a valid option if the patient is not a candidate for colonic stenting or when stenting expertise is not available. Weak recommendation, low quality evidence.
Article
Purpose: There is a lack of experience with covered self-expandable stents for benign colorectal disorders in children. Methods: Five children (4M, 1F) with a median age of 5years (range, 6months-9years) who underwent treatment with covered self-expandable plastic (SEPSs) or self-expandable metal stents (SEMSs) for a benign colorectal condition between April 2005 and November 2013 were recruited to this retrospective study. Etiologies included: anastomotic stricture with (n=1) or without (n=3) simultaneous enterocutaneous fistula, as well as an anastomotic leak associated with enterocutaneous fistula (n=1). All children suffered from either Hirschsprung's disease (n=3) or total colonic aganglionosis (Zuelzer-Wilson syndrome) (n=2). Results: Median duration of individual stent placement was 23days (range, 1-87days). In all cases up to five different stents were placed over time. At follow-up two patients were successfully treated without further intervention. In another patient the anastomotic stricture resolved fully, but a coexisting enterocutaneous fistula persisted. Overall, three patients did not improve completely following stenting and required definite surgery. Stent-related problems were noted in all cases. There was one perforation of the colon at stent insertion. Further complications consisted of stent dislocation (n=4), obstruction (n=1), formation of granulation tissue (n=1), ulceration (n=1) and discomfort (n=3). Conclusions: Covered self-expandable stents enrich the armamentarium of interventions for benign colorectal disorders in children including anastomotic strictures and intestinal leaks. A stent can be applied either as an emergency procedure (bridge to surgery) or as an adjuvant treatment further to endoscopy and dilatation. Postinterventional problems are frequent but there is a potential for temporary or definite improvement following stent insertion.